Rasna Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $4,238,414.

Profit Margin

Rasna Therapeutics, Inc. (OTC:RASP): Profit margin
2014 -350 -40.03K 11438.57%
2015 0 -16.75K
2016 0 -62.22K
2017 0 -4.43M
2018 0 -4.07M
2019 0 -936.38K
2020 0 -5.34M
2021 0 -1.30M
2022 0 -573.27K
2023 0 -4.44M

RASP Income Statement (2014 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue
Revenue
000000000-350
Cost of revenue
003141.63K3.47K03.46K000
Gross profit
00-314-1.63K-3.47K0-3.46K00-350
Operating exp.
Research and development
92.24K83.84K55.20K014.37K324.60K1.56M01.12M0
Selling and marketing
0000000000
Total operating expenses
4.23M383.91K247.81K556.50K915.17K4.07M4.53M62.22K16.75K40.03K
Operating income
-4.23M141.08K-247.81K-5.42M-915.17K-4.07M-4.53M-62.22K-16.75K-40.03K
Other income (expenses), net
-204.12K-827.67K-537.26K79.15K-28.79K-3.95K100.79K01.76M0
Income before tax
-4.44M-686.58K-785.08K-5.34M-943.96K-4.07M-4.43M-62.22K-16.75K-40.03K
Income tax expense
0-113.31K515.90K-3.03K-7.58K2.09K17.05K0-1.76M0
Net income
-4.44M-573.27K-1.30M-5.34M-936.38K-4.07M-4.43M-62.22K-16.75K-40.03K
Earnings per share
Basic EPS
-0.00-0.00-0.01-0.07-0.01-0.05-0.07-0.00-0.00-0.00
Diluted EPS
-0.00-0.00-0.01-0.07-0.01-0.05-0.07-0.00-0.00-0.00
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source